抗生素类具有强烈的体内活性,向格拉姆阴性细菌中的脂多糖合成
Douglas L Huseby1, Sha Cao1, Edouard Zamaratski2
1Department of Medical Biochemistry and Microbiology, BMC, Uppsala University, Uppsala SE-75123, Sweden.
概括
研究人员发现了一种新的抗生素类别,该类药物针对格兰氏阴性细菌中的脂多糖化物 (LPS) 合成. 这种新型抗生素在对抗大肠杆菌和K. pneumoniae等关键病原体方面表现出强大的疗效.
科学领域:
- 微生物学 微生物学
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
背景情况:
- 脂聚糖 (LPS) 合成是格拉姆阴性细菌的关键途径,为新型抗生素提供了可行的标.
- 在LPS合成中的LpxH酶是临床未开发的目标,没有人体类型,提供了选择性的治疗窗口.
- 现有的抗生素面临来自细菌流失机制和新兴耐药性的挑战.
研究的目的:
- 确定和开发一种新的抗生素类别,以向脂聚糖合物合成中的LpxH酶.
- 克服耐药机制,包括细菌排泄,在格拉姆阴性病原体.
- 为了实现强大的体内疗效,对关键的格拉姆阴性细菌感染.
主要方法:
- 现型查以识别针对LPS路径的初始命中.
- 基于结构的药物设计,利用X射线晶体学来优化抑制剂.
- 优化侧重于药物动力学特性,如溶解性,代谢稳定性和血清蛋白结合.
主要成果:
- 通过LpxH抑制作用的新型抗生素类的鉴定.
- 开发有效的抑制剂,对抗*Escherichia coli*的流失性和流失性高的野生型菌株.
- 在体内表现出强烈的有效性,对*大肠杆菌*和Klebsiella pneumoniae*引起的血液感染.
- 化合物在临床隔离物中没有先前存在的耐药性,并且对具有常见耐药性基因 (ESBL,MBL,卡巴酶) 的菌株保持了活性.
结论:
- 一种针对LpxH的新型抗生素已被确定并优化.
- 这些化合物显示出治疗由具有挑战性的格拉姆阴性病原体引起的感染的巨大潜力.
- 进一步开发可能会提供一种有价值的新武器来应对抗生素耐药性日益增长的威胁.
相关概念视频
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Types of RNA
63.6K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
63.6K
Antimicrobial Proteins
985
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
985
Antibiotic Selection
53.4K
Overview
53.4K
Defense Against Bacterial Pathogens
1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K


